1-109236451-G-A
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_006513.4(SARS1):c.1160G>A(p.Gly387Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0117 in 1,604,458 control chromosomes in the GnomAD database, including 158 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0089 ( 15 hom., cov: 32)
Exomes 𝑓: 0.012 ( 143 hom. )
Consequence
SARS1
NM_006513.4 missense
NM_006513.4 missense
Scores
2
6
10
Clinical Significance
Conservation
PhyloP100: 3.58
Genes affected
SARS1 (HGNC:10537): (seryl-tRNA synthetase 1) This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009588867).
BP6
Variant 1-109236451-G-A is Benign according to our data. Variant chr1-109236451-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 774395.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00892 (1358/152214) while in subpopulation NFE AF= 0.0142 (963/68018). AF 95% confidence interval is 0.0134. There are 15 homozygotes in gnomad4. There are 636 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 15 AR gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SARS1 | ENST00000234677.7 | c.1160G>A | p.Gly387Glu | missense_variant | Exon 9 of 11 | 1 | NM_006513.4 | ENSP00000234677.2 | ||
SARS1 | ENST00000369923.4 | c.1160G>A | p.Gly387Glu | missense_variant | Exon 9 of 12 | 5 | ENSP00000358939.4 | |||
SARS1 | ENST00000468588.1 | n.221G>A | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00893 AC: 1358AN: 152096Hom.: 15 Cov.: 32
GnomAD3 genomes
AF:
AC:
1358
AN:
152096
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00892 AC: 2243AN: 251456Hom.: 16 AF XY: 0.00868 AC XY: 1180AN XY: 135898
GnomAD3 exomes
AF:
AC:
2243
AN:
251456
Hom.:
AF XY:
AC XY:
1180
AN XY:
135898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0120 AC: 17368AN: 1452244Hom.: 143 Cov.: 32 AF XY: 0.0116 AC XY: 8377AN XY: 720070
GnomAD4 exome
AF:
AC:
17368
AN:
1452244
Hom.:
Cov.:
32
AF XY:
AC XY:
8377
AN XY:
720070
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00892 AC: 1358AN: 152214Hom.: 15 Cov.: 32 AF XY: 0.00855 AC XY: 636AN XY: 74416
GnomAD4 genome
AF:
AC:
1358
AN:
152214
Hom.:
Cov.:
32
AF XY:
AC XY:
636
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
57
ALSPAC
AF:
AC:
53
ESP6500AA
AF:
AC:
14
ESP6500EA
AF:
AC:
152
ExAC
AF:
AC:
1137
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
SARS1: PP2, BS1, BS2 -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome Benign:1
Sep 27, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at